Works matching IS 00071188 AND DT 2019 AND VI 176 AND IP 18
Results: 24
Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lovastatin attenuates hypertension induced by renal tubule-specific knockout of ATP-binding cassette transporter A1, by inhibiting epithelial sodium channels.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A<sub>2A</sub> receptor over-activation in a rat model of Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The potential of memory enhancement through modulation of perineuronal nets.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The proteostasis network provides targets for neurodegeneration.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A short perspective on the long road to effective treatments for Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Don't forget astrocytes when targeting Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treating Alzheimer's disease by targeting iron.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The involvement of microglia in Alzheimer's disease: a new dog in the fight.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2019, v. 176, n. 18, p. 3407, doi. 10.1111/bph.14415
- Publication type:
- Article